Xaliproden Hydrochloride

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameXaliproden Hydrochloride
Drug Alias NameXaliprodene盐酸扎利罗登XaliprodenoXaliprodenumXaprila +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor agonists
TargetsSerotonin 1a (5-HT1a) receptor
Therapy Area/IndicationsAlzheimer DiseaseNeoplasm MetastasisColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesSingapore +[20] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsAlzheimer DiseaseNeoplasm MetastasisColorectal Neoplasms

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG